Mitochondrial-Targeting Lonidamine-Doxorubicin Nanoparticles for Synergistic Chemotherapy to Conquer Drug Resistance-Reference-Cited by-同舟云学术

Mitochondrial-Targeting Lonidamine-Doxorubicin Nanoparticles for Synergistic Chemotherapy to Conquer Drug Resistance

Published:2017-12-07 Issue:50 Volume:9 Page:43498-43507
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Liu Yanqiu¹,Zhang Xiujuan¹,Zhou Mengjiao¹,Nan Xueyan¹,Chen Xianfeng²,Zhang Xiaohong¹^ORCID

Affiliation:

1. Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Institute of Functional Nano & Soft Materials (FUNSOM), Joint International Research Laboratory of Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu 215123, P.R. China

2. School of Engineering, Institute for Bioengineering, University of Edinburgh, Edinburgh EH9 3JL, United Kingdom

Funder

National Natural Science Foundation of China

Jiangsu Province Qing Lan Project

Collaborative Innovation Center of Suzhou Nano Science and Technology

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.7b14577